Trastuzumab Deruxtecan plus Pertuzumab for HER2-positive metastatic breast cancer - Tolaney, Sara; Jiang, Zefei; Zhang, Qingyuan; Barroso-Sousa, Romualdo; Park, Yeon Hee; Rimawi, Mothaffar F.; Saura, Cristina; Schneeweiss, Andreas; Toi, Masakazu; Chae, Yee Soo; Kemal, Yasemin; Chaudhari, Mukesh; et al. (The New England journal of medicine, 2025)
Veröffentlicht: 29. Oktober 2025